West Pharmaceutical Services competitors

José E. Almeida is a Brazilian businessman. He has served as the chairman and CEO of Baxter International, Inc. since January 2016. He worked for Tyco Healthcare from 1995 to 2002. He was president of Medical Devices division from October 2006 to June 2011. He served as chairman of the board of directors of Covidien since March 2012 and as the president, chief executive officer and a director since July 2011. He became a director of EMC Corporation on Jan 12, 2015 and resigned on October 30, 2015, due to his election as chairman and CEO of Baxter. In 2015, he worked for The Carlyle Group as an Operating Executive in the Global Healthcare group.

Bruce Dale Broussard is chief executive officer and president of Humana, a health insurance company with headquarters in Louisville, Kentucky.

Tyler has more than two decades of experience with McKesson, having served in a wide variety of leadership roles throughout the company. He has led nearly every major business within the company as well as McKesson’s corporate strategy and business development unit.

Robert M. Davis is corporate vice president and president of Baxter's Medical Products business. In this position, Davis oversees a range of products used in the delivery of fluids and drugs to patients, and in the treatment of end-stage kidney disease. Davis took on his current role in October 2010. Prior to this role, Davis served as corporate vice president and president of Baxter's Renal business. He served as corporate vice president and chief financial officer from 2006 through May 2010, and as treasurer from 2004 through 2006. Davis joined Baxter as treasurer in November 2004 from Eli Lilly and Company, where he served in numerous positions of increasing responsibility over 14 years. Davis currently serves on the Board of Trustees for Rush University Medical Center and also serves as a member of the Finance Committee. He also is a member of the Board of Directors of AdvaMed.

Ed was named president & chief executive officer of Owens & Minor, effective March 7, 2019, and was appointed to the board of directors at the same time. Prior to that, Ed served as an independent consultant and advisor in the healthcare, life science and distribution industries since January 2016. From January 2000 through April 2015, he served in various roles of increasing responsibility at Thermo Fisher Scientific, a $17 billion manufacturer and supplier of a range of products to the research, healthcare, industrial and safety markets, including most recently as chief commercial officer & senior vice president. Before joining Thermo Fisher Scientific, Ed spent eight years at TRW Inc., in a variety of finance roles and three years with PricewaterhouseCoopers as an auditor.

Ronald A. Rittenmeyer has served as a director of IQVIA since October 2016. Prior to this, Mr. Rittenmeyer served as a Director of IMS Health from April 2010 to October 2016. He served as Chairman, President and CEO of Expert Global Solutions, Inc. from 2008 to June 2014. Prior to that, Mr. Rittenmeyer served as Chairman, CEO and President of Electronic Data Systems Corporation from 2005 until 2008.He served as Chief Operating Officer of Electronic Data Systems Corporation from October 2005 until September 2007 (including service as Co-Chief Operating Officer until May 2006) and as Executive Vice President, Global Service Delivery from July 2005 until December 2006. Mr. Rittenmeyer also serves on the boards of directors of American International Group, Inc. and Tenet Health Care Corporation. He previously served as a director of EDS and RH Donnelley (presently Dex One Corporation). Mr. Rittenmeyer has a bachelor of arts degree in Commerce and Economics from Wilkes University, and his MBA from Rockhurst University. Mr. Rittenmeyer chairs the Leadership Development and Compensation Committee and serves as a member of the Audit Committee.

Vasant "Vas" Narasimhan is an American physician and the chief executive officer of Novartis (since 2018).